Leading pathologist, Dr. Sin Hang Lee, sent an open letter to the President and Premier of China asking for a delay in the scheduled HPV vaccination of Chinese children and young women ages 9-25. China’s population consists of approximately 143 million females age 9-25 . If human papillomavirus (HPV) vaccine manufacturers can convince the Chinese government to vaccinate every woman in this age group with 3 doses of HPV vaccine via a Publicly Funded Program as proposed by two of their paid consultants , the revenue generated could amount to over $64 billion USD (using price of HPV vaccines sold in the USA at $150/dose). This staggering amount of money would provide an enormous impact to their bottom line. But the question is at what cost?
Read more here: Dr. Sin Hang Lee recommends China postpone HPV vaccinations